autohct in dlbcl in the car-t era
Published 4 years ago • 75 plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
1:31
car-t therapy versus autosct in dlbcl
-
2:05
strategies to implement car-t in dlbcl
-
6:54
the future of car-t therapy in the management of dlbcl
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
3:05
can car-t cells replace asct in dlbcl?
-
2:42
clinical indications for car-t therapy in dlbcl & the possibility of moving car-t into earlier lines
-
2:06
can car-t cells replace asct in dlbcl?
-
3:47
can car-t cells replace asct in dlbcl?
-
11:34
chimeric antigen receptor car technique - creative biolabs (updated version)
-
5:01
b cells vs t cells | b lymphocytes vs t lymphocytes - adaptive immunity - mechanism
-
3:58
manufacturing car t cells to accelerate cancer immunotherapy research
-
3:05
car-t therapy in r/r dlbcl
-
2:06
car-t therapy vs autologous transplantation in r/r dlbcl
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
2:30
car-t cell therapy dlbcl landscape
-
1:33
car-t moving forwards for r/r dlbcl
-
1:02
the use of car-t cell products in a real-world setting
-
3:56
considerations and challenges of integrating car-t and transplantation in b-all
-
3:10
universal car-t therapy for t-all
-
2:12
fully human anti-cd19 and cd22 bispecific tandem car-t
-
1:39
the role of myeloid cells in car-t cell therapy
-
1:29
improving access to car-t therapy by reducing turnaround time